Unlock instant, AI-driven research and patent intelligence for your innovation.
Furan-azo- [3,2-g] chromene compound and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of compounds and compositions, applied in the directions of active ingredients of heterocyclic compounds, digestive system, organic chemistry, etc.
Active Publication Date: 2010-08-18
SHENYANG PHARMA UNIV
View PDF4 Cites 10 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
But clinically used tamoxifen and raloxifene can cause adverse reactions such as endometrial cancer and hot flashes (Fisher B, Costantino JP, Wickerham DL, et al.J Nati Cancer Inst, 1998, 90: 1371- 1388; Walsh BW, Kuller LH, Wild RA, et al. J Am Med Assoc, 1998, 279:1445-1451)
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0043] Example 1: Preparation of 2-benzoyl-3-(4-methoxyphenyl)-6,7-dihydro-5H-furo[3,2-g]chromene
[0044] Add 0.26 mol of 2', 4'-dihydroxyacetophenone into the round bottom flask, mix well with 232 mL of triethyl orthoformate, and slowly add 26.4 mL of perchloric acid thereinto. After reacting for 30 minutes, 300 mL of ether was added, and a solid was precipitated. Suction filtration, transfer the dried solid into a 1000mL round bottom flask, add 250mL hot water, reflux for two hours, suction filtration, recrystallization with ethanol to obtain 22.69g of 7-hydroxychromone, yield 53.2%, MS m / z (M) 162.
[0045] Put 0.15 mol of 7-hydroxychromone into a 1000 mL round bottom flask, add 2.50 g of 5% palladium carbon and 300 mL of ethanol, pass in hydrogen, react at 50 °C for 48 hours, remove the palladium carbon by suction filtration, and remove the ethanol by rotary evaporation. 21.39 g of 7-hydroxychroman was obtained, the yield was 92.4%, and MS m / z (M) was 150.
[0046] Dis...
Embodiment 2
[0049] Example 2: Preparation of 2-(4-methoxybenzoyl)-3-phenyl-6,7-dihydro-5H-furo[3,2-g]chromene
[0050] According to the method in Example 1, 0.65 grams of 2-(4-methoxybenzoyl)-3-phenyl-6,7-dihydro-5H-furo[3,2-g]chromene yellow crystals were obtained, Yield 60%, Mp: 130.3-132.5°C. ESI-MS m / z (M+1) 385.13; 1 HNMR (600MHz, CDCl 3 , δ: ppm) 2.04 (t, 2H, CH 2 ), 2.91(t, 2H, CH 2 ), 3.83 (s, 3H, OCH 3 ), 4.26(t, 2H, CH 2 ), 6.83(dd, 2H, ArH, J=7.0Hz, J=1.9Hz), 7.03(s, 1H, ArH), 7.30(s, 1H, ArH), 7.35-7.49(m, 5H, ArH), 7.90 (dd, 2H, ArH, J = 7.0 Hz, J = 1.9 Hz).
Embodiment 3
[0051] Example 3: Preparation of 2-(4-chlorobenzoyl)-3-(4-methoxyphenyl)-6,7-dihydro-5H-furo[3,2-g]chromene
[0052] According to the method of Example 1, 2-(4-chlorobenzoyl)-3-(4-methoxyphenyl)-6,7-dihydro-5H-furo[3,2-g]chromene was obtained 0.56 g of yellow crystals, yield 60%, Mp: 135.3-137.5°C. ESI-MS m / z (M+1) 419.13; 1 HNMR (600MHz, CDCl 3 , δ: ppm): 2.05(t, 2H, CH 2 ), 2.91(t, 2H, CH 2 ), 3.84(s, 3H, OCH 3 ), 4.27(t, 2H, CH 2 ), 6.92(dd, 2H, ArH, J=7.0Hz, J=1.9Hz), 7.00(s, 1H, ArH), 7.31-7.32(m, 3H, ArH), 7.40-7.41(m, 2H, ArH ), 7.80 (dd, 2H, ArH, J = 7.0 Hz, J = 1.9 Hz).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
diameter
aaaaa
aaaaa
length
aaaaa
aaaaa
composition ratio
aaaaa
aaaaa
Login to View More
Abstract
The invention relates to a furan-azo-[3,2-g] chromene derivative and application thereof, belonging to the technical field of medicine. The furan-azo-[3,2-g] chromene derivative comprises stereoisomers and pharmaceutically applicable salts of a compound of the furan-azo-[3,2-g] chromene derivative and has a structural general formula shown in the specification of the invention. The furan-azo-[3,2-g] chromene derivative and pharmaceutically applicable acid addition salts of the compound can be used as an estrogenreceptorregulator singly or by combining with traditional drugs to treat or prevent various diseases related to estrogen functions, such as bone loss, fracture, osteoporosis, hot flash, LDL (Low DensityLipoprotein) cholesterol level rise, angiocardiopathy, cognitive function impairment, brain-wasting diseases, anxiety, depression caused by estrogen shortage, inflammation, inflammatory bowel diseases, sexual dysfunction, hypertension, retinosis and cancer, especially breast cancer, ovarian cancer, osteosarcoma, endometrial cancer and prostatic cancer.
Description
technical field [0001] The invention relates to a furo[3,2-g]chromene compound, its pharmaceutical application as an estrogen receptor modulator, and a preparation method thereof. Background technique [0002] Compounds that mimic estrogen-like effects have a wide range of therapeutic and prophylactic applications, including: relief of menopausal symptoms, treatment of acne, treatment of dysmenorrhea and dysfunctional uterine bleeding, osteoporosis, prostatecancer and prevention of cardiovascular disease. [0003] Studies have found that there are two types of estrogen receptors: ERα and ERβ. After the ligand binds to these two isoforms, it exerts physiological effects with different tissue specificities. [0004] What is needed in the art is a compound that can produce a positive response like estrogen replacement therapy but without adverse side effects or with reduced side effects, and exert tissue-specific estrogen-like effects on the body. [0005] Furochromene deriv...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.